Clinical Trial: Prospective Phase II Clinical Study of Neoadjuvant Chemoradiotherapy Combined With PD-1/PD-L1 Inhibitors in the Treatment of Locally Advanced Resectable Esophageal Squamous Cell Carcinoma

U.S., March 22 -- ClinicalTrials.gov registry received information related to the study (NCT06888531) titled 'Prospective Phase II Clinical Study of Neoadjuvant Chemoradiotherapy Combined With PD-1/PD-L1 Inhibitors in the Treatment of Locally Advanced Resectable Esophageal Squamous Cell Carcinoma' on March 05.

Brief Summary: A prospective trial design was used to evaluate the efficacy and safety of neoadjuvant chemoradiotherapy combined with PD-1/PD-L1 inhibitors in the treatment of locally advanced resectable esophageal squamous cell carcinoma.

Study Start Date: March 08

Study Type: INTERVENTIONAL

Condition: Esophageal Malignant Neoplasm Primary

Intervention: COMBINATION_PRODUCT: Neoadjuvant chemoradiotherapy combined with PD-1/PD-L...